Showing 11-11 of 11 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Late pre-clinical validation of safety and long-term functionality of hypoimmunogenic iPSC-derived β cells into fully humanized transgenic mouse model of Type 1 Diabetes. | Università Vita-Salute San Raffaele | Lorenzo Piemonti | Cures | 01-December-2024 to 30-November-2027 | $999,995.70 |